此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

CCTA to Optimize the Diagnostic Yield of Invasive Angiography (CarDIA)

2022年3月14日 更新者:Hamilton Health Sciences Corporation

Coronary Computed Tomographic Angiography to Optimize the Diagnostic Yield of Invasive Angiography in Lower Risk Patients

This study aims to reduce patient risk and costs to the healthcare system by improving the diagnostic yield of invasive coronary angiography through existing triage processes to improve risk stratification using Coronary Computed Tomographic Angiography (CCTA) as a first step in low risk patients. All low-risk patients referred for invasive coronary angiography will be potentially eligible for CCTA instead of invasive angiography as a first-line diagnostic test. All CCTAs will be read by both a level 3-trained cardiologist and a radiologist. The results of the CCTA, coupled with evidence-based management recommendations will be sent to the referring physician and an invasive angiogram will be arranged by the HIU triage, only when clearly indicated

研究概览

研究类型

观察性的

注册 (实际的)

186

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

    • Ontario
      • Hamilton、Ontario、加拿大、L8L 2X2
        • Hamilton General Hospital

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 至 75年 (成人、年长者)

接受健康志愿者

有资格学习的性别

全部

取样方法

非概率样本

研究人群

All eligible low-risk patients referred for invasive angiography will be recruited from the two interventional sites (approximately 240) via centralized triage process. Patients treated before the intervention implementation will be the control group (approximately 480).

描述

Inclusion Criteria:

  1. Non urgent outpatient referral
  2. Canadian Cardiovascular Society class I or II
  3. Indication for invasive angiogram includes: Rule out Coronary Artery Disease (CAD) and Cardiomyopathy

Exclusion Criteria:

  1. Age <18 years old, Men >65 years old or women >75 years old
  2. Patient refusal to provide verbal consent for CCTA at time of triage contact or unable to provide informed consent
  3. Referring physician refusal for their eligible patients to be approached for the CarDIA study
  4. Any prior CCTA
  5. Atrial Fibrillation
  6. Creatinine > 150 mmol/L
  7. Diabetes mellitus
  8. High risk Exercise Stress Test or Functional Imaging
  9. Known severe valvular disease being considered for valve surgery
  10. Any known CAD

    • Prior Acute Coronary Syndrome (ACS)
    • Prior Percutaneous Coronary Intervention (PCI) or Coronary Artery Bypass Graft (CABG)

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

队列和干预

团体/队列
干预/治疗
Intervention Group
All low-risk patients referred for invasive coronary angiography through the Hamilton General Hospital's Heart Investigation Unit Triage will be potentially eligible to receive the intervention over a 12-month period. The intervention will include risk stratification with CCTA at HHS and NHS as an alternative to upfront invasive angiography.
All low-risk patients referred for invasive coronary angiography will be potentially eligible to receive the intervention over a 12-month period. The intervention will include risk stratification using Coronary Computed Tomographic Angiography (CCTA) at HHS and NHS as an alternative to upfront invasive angiography. All CCTAs will be read by both a level 3-trained cardiologist and a radiologist. The results of the CCTA, coupled with evidence-based management recommendations will be sent to the referring physician and an invasive angiogram will be arranged only when indicated as per these management recommendations
Control Group
Intervention sites will act as their own controls: outcomes of all eligible patients in the 24-months prior to the implementation of the intervention will be assessed from a routinely collected health administrative database. Eligible patients not undergoing CCTA (patient or physician refusal, or CCTA not available) will be captured and included in the control group as part of a sensitivity analysis during the intervention period

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Diagnostic yield of invasive angiography
大体时间:Three years
Diagnostic yield is defined as the proportion of invasive angiograms that identify significant disease (≥70% stenosis) on a major coronary vessel (>2 mm) or > 50% stenosis in the left main)
Three years

次要结果测量

结果测量
措施说明
大体时间
Quantitative assessment of angiograms avoided
大体时间:Three years
Number of angiograms avoided due to CCTA bookings
Three years
Deviation from management recommendations following CCTA
大体时间:Three years
Number of angiograms performed when not recommended
Three years
Protocol deviation as a surrogate for acceptability of the novel triage program
大体时间:Three years
Percentage of patients and physicians refusing to undergo CCTA as a first step
Three years
Costing of new strategy
大体时间:Three years
Cost of risk stratification of Coronary Artery Disease in low risk patients
Three years

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 首席研究员:Jon-David Schwalm, MD,FRCPC,Msc、Hamilton Health Sciences Corporation
  • 首席研究员:Tej Sheth, Bsc,FRCPC,MD、Hamilton Health Sciences Corporation

出版物和有用的链接

负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。

一般刊物

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2018年7月9日

初级完成 (实际的)

2020年2月28日

研究完成 (实际的)

2022年3月1日

研究注册日期

首次提交

2018年5月30日

首先提交符合 QC 标准的

2018年5月30日

首次发布 (实际的)

2018年6月12日

研究记录更新

最后更新发布 (实际的)

2022年3月16日

上次提交的符合 QC 标准的更新

2022年3月14日

最后验证

2022年3月1日

更多信息

与本研究相关的术语

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

药物和器械信息、研究文件

研究美国 FDA 监管的药品

研究美国 FDA 监管的设备产品

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

3
订阅